CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism

Open access

Abstract

The pathogenesis of cardiovascular (CV) mortality, whose rate is increased in type 2 diabetes, is poorly understood. While high serum adiponectin is associated with increased CV mortality in the general population, no data are available in type 2 diabetes. We here investigated whether this counterintuitive association was observable also in diabetic patients and whether it was sex-specific. Three prospective cohorts were analyzed: 1) Gargano Heart Study (GHS; 359 patients, 58 events/1,934 person-years; py); 2) Health Professional Follow-up Study (HPFS; 833 men, 146 events/10,024 py); 3) Nurses’ Health Study (NHS; 902 women, 144 events/15,074 py). In GHS serum adiponectin predicted CV mortality in men (hazard ratio, HR, and 95% CI per standard deviation, SD, increment = 1.54, 1.19-2.01), but not women (HR = 0.98, 0.48-2.01). Circulating adiponectin predicted CV mortality in men from HPFS (HR = 1.44, 1.21-1.72), but not in women from NHS (HR = 1.08, 0.86-1.35), used as replication samples. In a pooled analysis, HRs were 1.47 (1.27-1.70) in 1,075 men and 1.07 (0.86-1.33) in 1,019 women (p for HRs heterogeneity across sexes = 0.018). This is the first report showing that high circulating adiponectin predicts increased CV mortality in men, but not in women with type 2 diabetes. Further studies are necessary to unravel the mechanisms through which adiponectin influences CV mortality in a sex-specific manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-014-0130-y

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Hazard ratios (95% CI) of CV mortality in men from the GHS-prospective design and HPFS, according to baseline tertile of circulating adiponectin levels (T1-T3, range in parentheses). Hazard ratios were estimated by Cox regression after adjusting for age, sex, smoking habits, BMI, HbA1c, anti-diabetic therapy, hypertension, total cholesterol, HDL cholesterol, triglycerides and hsCRP.
Figure 1 Hazard ratios (95% CI) of CV mortality in men from the GHS-prospective design and HPFS, according to baseline tertile of circulating adiponectin levels (T1-T3, range in parentheses). Hazard ratios were estimated by Cox regression after adjusting for age, sex, smoking habits, BMI, HbA1c, anti-diabetic therapy, hypertension, total cholesterol, HDL cholesterol, triglycerides and hsCRP.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 40

Metadata

Authors
Menzaghi, C., Xu, M., Salvemini, L., De Bonis, C., Palladino, G., Huang, T., Copetti, M., Zheng, Y., Li, Y., Fini, G., Hu, F. B., Bacci, S., Qi, L., & Trischitta, V.
Affiliations
  • Casa Sollievo della Sofferenza (IT)
  • Harvard University (US)
  • Brigham and Women's Hospital (US)
Corresponding author
  • Menzaghi, Claudia
  • Trischitta, Vincenzo
Venue
Cardiovascular Diabetology
Published
2014-09-10
Volume
13
Issue
1
Pages
130-130
ISSN
1475-2840 (ISSN-L)
OpenAlex
W2139950016
Cited by
40
References
52
Citations by year
2026: 1 · 2024: 3 · 2023: 5 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 6
FWCI
5.05
Type
journal article
Language
en
Open access
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Funders
  • American Heart Association
  • Pfizer
  • Brigham and Women's Hospital
  • European Foundation for the Study of Diabetes
  • National Natural Science Foundation of China (81270877)
  • Ministero della Salute (RC-2014, RC 2013)
  • Sapienza Università di Roma
  • Shanghai Jiao Tong University
  • Regione Puglia
  • Ruijin Hospital
  • School of Medicine, Shanghai Jiao Tong University
  • European Regional Development Fund (2007 – 2013)
  • National Heart, Lung, and Blood Institute (R01HL071981, DK46200, HL-071981, DK091718)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK091718, DK091718, P30DK046200, HL071981, DK46200.)
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
adiponectin, cardiovascular mortality, type 2 diabetes, sex differences, sex-specific association, cardiovascular risk prediction, Health Professionals Follow-up Study, Nurses' Health Study
MeSH terms
Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Sex Characteristics, Incidence, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism. https://app.cochat.ai/papers/10.1186/s12933-014-0130-y
The paper
Menzaghi, C., Xu, M., Salvemini, L., De Bonis, C., Palladino, G., Huang, T., Copetti, M., Zheng, Y., Li, Y., Fini, G., Hu, F. B., Bacci, S., Qi, L., & Trischitta, V. (2014). Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-014-0130-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.